Publications by authors named "Miranda Peeples"

Claim this Profile
T
Time to treatment failure following initiation of fingolimod versus teriflunomide for multiple sclerosis: a retrospective US claims study.
Maria Cecilia Vieira, Devon Conway, Gina Mavrikis Cox, Miranda Peeples, Arielle G Bensimon

Curr Med Res Opin· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world durability of relapse rate reduction in patients with multiple sclerosis receiving fingolimod for up to 3 years: a retrospective US claims database analysis.
Edward Fox, Maria Cecilia Vieira, Kristen Johnson, Miranda Peeples, Arielle G Bensimon

J Neurol Sci· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potentially High Number of Ineffective Drugs with the Standard Shorter Course Regimen for Multidrug-Resistant Tuberculosis Treatment in Haiti.
Kathleen F Walsh, Ariadne Souroutzidis, Stalz Charles Vilbrun, Miranda Peeples, Guy Joissaint

Am J Trop Med Hyg· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epilepsy treatment patterns among patients with tuberous sclerosis complex.
Jinlin Song, Elyse Swallow, Qayyim Said, Miranda Peeples, Mark Meiselbach

J Neurol Sci· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world utilization of molecular diagnostic testing and matched drug therapies in the treatment of metastatic cancers.
Anita Chawla, Miranda Peeples, Nanxin Li, Rachel Anhorn, Jason Ryan

J Med Econ· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Economic Outcomes During Time on Treatment Among Patients Who Initiated Sunitinib or Pazopanib as First Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Analysis of Medicare Claims Data.
Nicholas J Vogelzang, Sumanta K Pal, Sameer R Ghate, Nanxin Li, Elyse Swallow, Miranda Peeples

J Manag Care Spec Pharm· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line treatment disruption among post-menopausal women with HR+/HER2- metastatic breast cancer: a retrospective US claims study.
Derek H Tang, Nanxin Li, Ella X Du, Miranda Peeples, Lihao Chu

Curr Med Res Opin· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Economic Outcomes in Elderly Advanced Renal Cell Carcinoma Patients Starting Pazopanib or Sunitinib Treatment: A Retrospective Medicare Claims Analysis.
Nicholas J Vogelzang, Sumanta K Pal, Sameer R Ghate, Elyse Swallow, Nanxin Li, Miranda Peeples

Adv Ther· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Survival Outcomes and Prognostic Factors Among Patients Receiving First Targeted Therapy for Advanced Renal Cell Carcinoma: A SEER-Medicare Database Analysis.
Sumanta K Pal, Sameer R Ghate, Nanxin Li, Elyse Swallow, Miranda Peeples

Clin Genitourin Cancer· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world palbociclib dosing patterns and implications for drug costs in the treatment of HR+/HER2- metastatic breast cancer.
Nanxin Li, Ella X Du, Lihao Chu, Miranda Peeples, Jipan Xie

Expert Opin Pharmacother· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of Disease Monitoring and Treatment Among Patients With Tuberous Sclerosis Complex-related Angiomyolipomas.
Elyse Swallow, Sarah King, Jinlin Song, Miranda Peeples, James E Signorovitch

Urology· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of medical costs and healthcare resource utilization of post-menopausal women with HR+/HER2- metastatic breast cancer receiving everolimus-based therapy or chemotherapy: a retrospective claims database analysis.
Nanxin Li, Yanni Hao, Valerie Koo, Anna Fang, Miranda Peeples

J Med Econ· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time on treatment of everolimus and chemotherapy among postmenopausal women with hormone-receptor-positive/human-epidermal-growth-factor-receptor-2-negative metastatic breast cancer: a retrospective claims study in the US.
Nanxin Li, Yanni Hao, Andrew Kageleiry, Miranda Peeples, Anna Fang

Curr Med Res Opin· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and factors associated with the use of everolimus among post-menopausal women with HR+/HER2- metastatic breast cancer: a retrospective US claims study.
Annie Guérin, Yanni Hao, Derek Tang, Miranda Peeples, Anna Fang

Expert Opin Pharmacother· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Analysis of Medical Costs and Healthcare Resource Utilization in Elderly Women with HR+/HER2- Metastatic Breast Cancer Receiving Everolimus-Based Therapy or Chemotherapy.
Yanni Hao, Nanxin Li, Anna P Fang, Valerie Koo, Miranda Peeples

Adv Ther· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daclatasvir and Sofosbuvir Versus Sofosbuvir and Ribavirin in Patients with Chronic Hepatitis C Coinfected with HIV: A Matching-adjusted Indirect Comparison.
Elyse Swallow, Jinlin Song, Yong Yuan, Anupama Kalsekar, Caroline Kelley, Miranda Peeples

Clin Ther· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis